EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 135 filers reported holding EPIZYME INC in Q2 2019. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $266,000 | -4.7% | 31,985 | 0.0% | 0.00% | – |
| Q1 2021 | $279,000 | -90.1% | 31,985 | -87.7% | 0.00% | -100.0% |
| Q4 2020 | $2,830,000 | -19.6% | 260,552 | -11.7% | 0.00% | -25.0% |
| Q3 2020 | $3,519,000 | -23.2% | 294,956 | +3.4% | 0.00% | -20.0% |
| Q2 2020 | $4,583,000 | +10.8% | 285,341 | +7.0% | 0.01% | -16.7% |
| Q1 2020 | $4,136,000 | +47.8% | 266,677 | +134.4% | 0.01% | +100.0% |
| Q4 2019 | $2,799,000 | +336.7% | 113,780 | +82.1% | 0.00% | +200.0% |
| Q3 2019 | $641,000 | -18.2% | 62,472 | -0.1% | 0.00% | 0.0% |
| Q2 2019 | $784,000 | -89.5% | 62,518 | -79.9% | 0.00% | -87.5% |
| Q2 2015 | $7,464,000 | -24.3% | 311,000 | -40.8% | 0.01% | -27.3% |
| Q1 2015 | $9,861,000 | – | 525,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |